Clinical Takeaway
A mobile app called Minder, co-designed with university students, was tested in a randomized controlled trial to address mental health and substance use challenges that commonly emerge during the college years. Digital tools like this are being studied because they can reach large numbers of students in a scalable and accessible way. The results of this trial provide evidence on whether app-based interventions can meaningfully improve mental health and substance use outcomes in a real-world student population.
#5 Effectiveness of the Minder Mobile Mental Health and Substance Use Intervention for University Students: Randomized Controlled Trial.
Citation: Vereschagin Melissa et al.. Effectiveness of the Minder Mobile Mental Health and Substance Use Intervention for University Students: Randomized Controlled Trial.. Journal of medical Internet research. 2024. PMID: 38536225.
Design: 5 Journal: 0 N: 3 Recency: 1 Pop: 2 Human: 1 Risk: 0
This study evaluates a scalable digital intervention addressing the critical clinical gap in mental health and substance use treatment accessibility during a high-risk developmental period when these disorders commonly emerge. The randomized controlled trial design provides evidence necessary to determine whether mobile app-based interventions can effectively reduce symptom burden and substance use in a population with documented barriers to traditional care access. Positive findings would support the integration of evidence-based digital tools into university health services and establish a model for reaching underserved student populations at a formative stage of illness.
Abstract: BACKGROUND: University attendance represents a transition period for students that often coincides with the emergence of mental health and substance use challenges. Digital interventions have been identified as a promising means of supporting students due to their scalability, adaptability, and acceptability. Minder is a mental health and substance use mobile app that was codeveloped with university students. OBJECTIVE: This study aims to examine the effectiveness of the Minder mobile app in improving mental health and substance use outcomes in a general population of university students. METHODS: A 2-arm, parallel-assignment, single-blinded, 30-day randomized controlled trial was used to evaluate Minder using intention-to-treat analysis. In total, 1489 participants were recruited and randomly assigned to the intervention (n=743, 49.9%) or waitlist control (n=746, 50.1%) condition. The Minder app delivers evidence-based content through an automated chatbot and connects participants with services and university social groups. Participants are also assigned a trained peer coach to support them. The primary outcomes were measured through in-app self-assessments and included changes in general anxiety symptomology, depressive symptomology, and alcohol consumption risk measured using the 7-item General Anxiety Disorder scale, 9-item Patient Health Questionnaire, and US Alcohol Use Disorders Identification Test-Consumption Scale, respectively, from baseline to 30-day follow-up. Secondary outcomes included measures related to changes in the frequency of substance use (cannabis, alcohol, opioids, and nonmedical stimulants) and mental well-being. Generalized linear mixed-effects models were used to examine each outcome. RESULTS: In total, 79.3% (589/743) of participants in the intervention group and 83% (619/746) of participants in the control group completed the follow-up survey. The intervention group had significantly greater average reductions in anxiety symptoms measure
🧠 This randomized controlled trial examines a student-codeveloped mobile app for mental health and substance use support during a developmentally sensitive transition period, which is methodologically sound and addresses a genuine public health need. However, several important limitations warrant cautious interpretation: the study population is restricted to university students, outcomes may not generalize to broader populations or to individuals with more severe substance use disorders, and the typical challenges of digital intervention research including selection bias, engagement decay, and the difficulty in isolating the active ingredients of app-based interventions all apply here. Additionally, we cannot yet determine from the abstract alone whether cannabis use specifically was measured as a primary or secondary outcome, or whether the app’s effectiveness differs meaningfully across different substance categories. In clinical practice, while brief digital interventions show promise for early-stage mental health concerns and mild substance use patterns in motivated student populations, they should be integrated into rather than substituted for traditional assessment and care when working with university patients reporting significant symptoms or escalating use.